Evidence map›Paper›PMID 35219329›Full record

ArticleRespiratory research2022

CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.

Huanbin Liu, Shuna Liu, Jinjun Jiang, Yidi Zhang, Yulong Luo, Jingxin Zhao, Jian Xu, Yuan Xie, Weiping Liao, Wei Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Coenzyme Q10: Role in Less Common Age-Related Disorders.Antioxidants (Basel, Switzerland) · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Huanbin Liu *School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Shuna Liu *School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Jinjun Jiang *School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Yidi ZhangSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Yulong LuoState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
Jingxin ZhaoSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Jian XuSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Yuan XieSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Weiping LiaoFoshan Fourth People's Hospital, Foshan, 528000, People's Republic of China.
Wei WangFoshan Fourth People's Hospital, Foshan, 528000, People's Republic of China.
Yichu NieSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China. nieych3@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-6746-2598
Shiyue LiState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China. lishiyue@188.com.
Wenbin DengSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Guangzhou, 510275, People's Republic of China.
Sun Yat-sen University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNThe Fourth People's Hospital · CN

Funding

high-level hospital construction opening project of foshan fourth people's hospital FSSYKF-2020010international postdoctoral exchange fellowship program 20150075pearl river nova program of guangzhou (cn) 201806010008state key laboratory of respiratory disease SKLRD-OP-201905
6 · The paper itself

Abstract

backgroundRecent studies have demonstrated that airway basal stem cells (BCs) transplantation can ameliorate bleomycin-induced idiopathic pulmonary fibrosis (IPF) through lung regeneration promotion. However, BCs under oxidative stress in the alveolar microenvironment are poor in survival, causing unsatisfied efficacy of BCs transplantation. In this study, we investigated whether Coenzyme Q10(CoQ10) counteracts oxidative stress in the alveolar microenvironment, thus improved the efficacy of BCs transplantation for IPF treatment.

methodsThe protective effects of CoQ10 on H

resultsCoQ10 preincubation with BCs (10 mM, 24 h) significantly reduced the late apoptosis of BCs and the number of oxidative stressful BCs as a result of H

conclusionCoQ10 blocked H

Indexed as

AnimalsApoptosisBleomycinCells, CulturedDisease Models, AnimalHumansIdiopathic Pulmonary FibrosisMaleMiceMice, Inbred C57BLOxidative StressRegenerationStem Cell TransplantationUbiquinoneBleomycincoenzyme Q10UbiquinoneAirway basal stem cells (BCs)Cell transplantationCoenzyme Q10 (CoQ10)Idiopathic pulmonary fibrosis (IPF)

Identifiers

PMID35219329
PMCPMC8882301
OpenAlexW4220678828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.